SMO and meningioma: Recurrent somatic mutations in SMO, which represent the primary route to Hh pathway activation in meningiomas, were observed in tumors originating from the midline anterior or middle cranial fossa14, an area where this pathway is embryologically active in development of the brain and other tissues46,47.